Skip to content
GLP-1/GIP/Glucagon triple agonist Pending FDA approval

Retatrutide Results & Timeline (2026)

Simultaneously activates three receptors — GLP-1, GIP, and glucagon — producing stronger appetite suppression and metabolic effects than dual or single agonists. Average weight loss: 24% in clinical trials.

24%

Avg Weight Loss

Not yet available (pending FDA approval)

Compounded Price

Weekly

Injection Frequency

4

Dose Options

Retatrutide Results and Timeline

Understanding what results to expect and when helps you stay motivated throughout your Retatrutide treatment.

Clinical Trial Results

In the Phase 3 TRIUMPH trials (ongoing) clinical trial, participants taking Retatrutide achieved an average weight loss of 24% of their body weight over 12-18 months. Individual results vary based on dosage, diet, exercise, and other factors.

Month-by-Month Timeline

  • Month 1: Initial low dose, appetite reduction begins, 3-5 lbs lost
  • Months 2-3: Dose increases, consistent 1-2 lbs/week weight loss
  • Months 4-6: Approaching therapeutic dose, steady progress
  • Months 6-12: Maximum dose, continued weight loss with possible slowing
  • Months 12-18: Peak results, transition to weight maintenance
Get Retatrutide - Start Free Assessment This is an affiliate link. We may earn a commission at no extra cost to you.

Retatrutide FAQ

How much does Retatrutide cost?

Compounded Retatrutide costs Not yet available (pending FDA approval) through telehealth providers. Brand-name versions (Pending FDA approval) cost Not yet available (Phase 3 trials) without insurance.

How much weight can I lose on Retatrutide?

Clinical trials show an average weight loss of 24% of body weight on Retatrutide. Individual results vary based on dosage, diet, and exercise habits.

What are Retatrutide side effects?

Common side effects include nausea, diarrhea, decreased appetite, vomiting, constipation. Most side effects are temporary and resolve within 4-8 weeks as your body adjusts.

Is Retatrutide taken daily or weekly?

Retatrutide is administered as a weekly subcutaneous injection. It uses a pre-filled pen device for subcutaneous injection.

What doses is Retatrutide available in?

Retatrutide is available in 1mg, 4mg, 8mg, 12mg doses. Treatment starts at the lowest dose and increases every 4 weeks.

More About Retatrutide

Compare Other Medications